Cargando…
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness
Aberrant CXCR4 activity has been implicated in lymphoma pathogenesis, disease progression, and resistance to therapies. Using a mouse model with a gain-of-function CXCR4 mutation (CXCR4(C1013G)) that hyperactivates CXCR4 signaling, we identified CXCR4 as a crucial activator of multiple key oncogenic...
Autores principales: | Lewis, Richard, Maurer, H. Carlo, Singh, Nikita, Gonzalez-Menendez, Irene, Wirth, Matthias, Schick, Markus, Zhang, Le, Isaakidis, Konstandina, Scherger, Anna Katharina, Schulze, Veronika, Lu, Junyan, Zenz, Thorsten, Steiger, Katja, Rad, Roland, Quintanilla-Martinez, Leticia, Espeli, Marion, Balabanian, Karl, Keller, Ulrich, Habringer, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8478649/ https://www.ncbi.nlm.nih.gov/pubmed/34363012 http://dx.doi.org/10.1038/s41375-021-01376-1 |
Ejemplares similares
-
AID Contributes to Accelerated Disease Progression in the TCL1 Mouse Transplant Model for CLL
por: Schubert, Maria, et al.
Publicado: (2021) -
Exome sequencing of the TCL1 mouse model for CLL reveals genetic heterogeneity and dynamics during disease development
por: Zaborsky, Nadja, et al.
Publicado: (2018) -
Effective Tcl/Tk programming: writing better programs with Tcl and Tk
por: Harrison, Mark, et al.
Publicado: (1998) -
p53-independent ibrutinib responses in an Eμ-TCL1 mouse model demonstrates efficacy in high-risk CLL
por: Lee, H J, et al.
Publicado: (2016) -
Tcl and the Tk toolkit /
por: Ousterhout, John K.
Publicado: (1994)